SIM
CRMD icon

Spark Investment Management’s CorMedix CRMD Stock Holding History

Spark Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,680
Closed -$146K – 648
2014
Q1 		$146K Buy
+11,680
New +$137K 0.02% 571

Other funds holding CRMD

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Spark Investment Management's CRMD Position: Q2 2014 in Review

Spark Investment Management sold out of CorMedix (CRMD) in Q2 2014, closing a stake of 11,680 shares — an estimated $146K sold.

Spark Investment Management first reported a position in CRMD in Q1 2014 and held it in 1 quarter. The position peaked at $146K in Q1 2014. 12 funds tracked by Wall St. Rank hold CRMD as of Q2 2014.

  • Spark Investment Management reported no remaining CorMedix position as of Q2 2014 after selling out during the quarter.
  • Spark Investment Management sold 11,680 CorMedix shares in Q2 2014, an estimated $146K.
  • Spark Investment Management first reported a position in CorMedix in Q1 2014 and held it in 1 quarter.
  • Spark Investment Management's CorMedix position peaked at $146K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held CorMedix as of Q2 2014.

Based on Spark Investment Management's 13F filing for Q2 2014, filed 12 Aug 2014.